{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:02:09Z","timestamp":1787025729250,"version":"build-2736575974"},"reference-count":28,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECT<\/jats:title>\n                    <jats:p>Cushing's disease (CD) is a potentially lethal neuroendocrinopathy that often requires specialized multidisciplinary treatment to achieve optimized outcomes. The authors analyzed data pertaining to patient, hospital, and admission characteristics as they relate to outcomes following transsphenoidal surgery (TSS) in more than 5500 patients treated for CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The Nationwide Inpatient Sample (NIS) database was used to identify all patients admitted with CD between 2002 and 2010. A variety of patient demographic data (e.g., age, sex, race, payer status), hospital variables (e.g., bed size, TSS volume, teaching status), and admission subtypes (e.g., elective, emergency) were tested for association with postoperative endocrine and nonendocrine complications, mortality, nonroutine discharge, length of stay, and total hospital charges. All tests were performed using univariate analysis followed by multivariate analysis, with 4 models tested via an additive methodology. Statistical significance was defined as a p value &lt; 0.05 for all analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>From 2002 to 2010, 5527 individuals who were admitted for TSS (54 biopsies, 4254 partial resections, and 1271 total resections; 5579 total TSS procedures) were identified as patients with CD. There were 25 deaths following TSS, resulting in a mortality incidence rate of 0.45%. Nonendocrine and endocrine complications were reported in 22.4% and 11.1% of patients, respectively. The most common nonendocrine complications were postoperative neurological complications (6.98%) and mechanical ventilation (1.71%). Diabetes insipidus was reported in 14.79% of patients. In a multivariate analysis, patients with Medicare were at increased risk of nonendocrine complications (relative risk [RR] 2.24, 95% CI 1.15\u20134.38; p = 0.02). Patients with Medicare had increased risk of higher charges (RR 1.89, 95% CI 1.04\u20133.45; p = 0.04), as did those with Medicaid (RR 1.93, 95% CI 1.10\u20133.41; p = 0.02). Additionally, as compared with white patients, Hispanic patients had an increased rate of higher charges (RR 1.86, 95% CI 1.12\u20133.10; p = 0.02). Patients whose age was less than 40 years had a higher risk of developing diabetes insipidus (RR 1.39, 95% CI 1.0\u20131.93; p = 0.05). When compared with those in northeast hospitals, patients in western hospitals were more likely to experience nonendocrine complications (RR 1.85, 95% CI 0.99\u20133.46; p = 0.05) and endocrine complications (RR 1.98, 95% CI 1.28\u20133.07; p &lt; 0.01). Patients treated in teaching hospitals were at significantly lower risk of incurring higher hospital charges (RR 0.49, 95% CI 0.28\u20130.85; p = 0.01). Patients with emergency admissions had a risk of higher hospital charges (RR 3.06, 95% CI 1.26\u20137.46; p = 0.01) and nonendocrine complications (RR 3.18, 95% CI 1.22\u20138.28; p = 0.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>This review of NIS data in more than 5500 patients treated surgically for CD pointed to major outcome disparities predicted primarily by payer status, admission type, and hospital region. Identification and targeting of such barriers to quality health care in patients with CD may help optimize patient outcomes on a national level and present an opportunity to improve access of high-risk patient subgroups to specialty centers of excellence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2014.11.focus14694","type":"journal-article","created":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T03:40:53Z","timestamp":1422762053000},"page":"E2","source":"Crossref","is-referenced-by-count":27,"title":["Demographic factors, outcomes, and patient access to transsphenoidal surgery for Cushing's disease: analysis of the Nationwide Inpatient Sample from 2002 to 2010"],"prefix":"10.3171","volume":"38","author":[{"given":"Daniel","family":"Wilson","sequence":"first","affiliation":[{"name":"Albany Medical College, Albany, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Jin","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wen","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carmichael","sequence":"additional","affiliation":[{"name":"Departments of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Cen","sequence":"additional","affiliation":[{"name":"Neurology,"},{"name":"Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Mack","sequence":"additional","affiliation":[{"name":"Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Zada","sequence":"additional","affiliation":[{"name":"Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-focus14694","series-title":"Acta Endocrinol (Copenh)","first-page":"423","article-title":"A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome","volume":"123","author":"Arnott","year":"1990"},{"key":"b2-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"4709","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003"},{"key":"b3-focus14694","series-title":"J Neurosurg","first-page":"520","article-title":"Repeat transsphenoidal surgery for Cushing's disease","volume":"71","author":"Friedman","year":"1989"},{"key":"b4-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"1776","article-title":"Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure","volume":"82","author":"Graham","year":"1997"},{"key":"b5-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"1056","article-title":"Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies","volume":"66","author":"Guilhaume","year":"1988"},{"key":"b6-focus14694","series-title":"Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001","author":"Houchens","year":"2005"},{"key":"b7-focus14694","series-title":"Neurochirurgie","first-page":"294","article-title":"Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery","volume":"48","author":"Laws","year":"2002"},{"key":"b8-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"2475","article-title":"Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood","volume":"80","author":"Leinung","year":"1995"},{"key":"b9-focus14694","series-title":"Am J Rhinol","first-page":"281","article-title":"Endoscopic transnasal pituitary surgery: report on 180 cases","volume":"15","author":"Nasseri","year":"2001"},{"key":"b10-focus14694","series-title":"N Engl J Med","first-page":"243","article-title":"Results of treatment in 108 patients with Cushing's syndrome","volume":"285","author":"Orth","year":"1971"},{"issue":"3","key":"b11-focus14694","series-title":"Neurosurg Focus","first-page":"E7","article-title":"National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002","volume":"23","author":"Patil","year":"2007"},{"key":"b12-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"1122","article-title":"Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease","volume":"69","author":"Pieters","year":"1989"},{"key":"b13-focus14694","series-title":"Clin Endocrinol (Oxf)","first-page":"621","article-title":"Transsphenoidal microsurgery for Cushing's disease","volume":"21","author":"Semple","year":"1984"},{"key":"b14-focus14694","series-title":"Endocrinol Metab Clin North Am","first-page":"459","article-title":"Pituitary surgery and postoperative management in Cushing's disease","volume":"34","author":"Utz","year":"2005"},{"key":"b1-focus14694","series-title":"Acta Endocrinol (Copenh)","first-page":"423","article-title":"A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome","volume":"123","author":"Arnott","year":"1990"},{"key":"b2-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"4709","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003"},{"key":"b3-focus14694","series-title":"J Neurosurg","first-page":"520","article-title":"Repeat transsphenoidal surgery for Cushing's disease","volume":"71","author":"Friedman","year":"1989"},{"key":"b4-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"1776","article-title":"Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure","volume":"82","author":"Graham","year":"1997"},{"key":"b5-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"1056","article-title":"Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies","volume":"66","author":"Guilhaume","year":"1988"},{"key":"b6-focus14694","series-title":"Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001","author":"Houchens","year":"2005"},{"key":"b7-focus14694","series-title":"Neurochirurgie","first-page":"294","article-title":"Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery","volume":"48","author":"Laws","year":"2002"},{"key":"b8-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"2475","article-title":"Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood","volume":"80","author":"Leinung","year":"1995"},{"key":"b9-focus14694","series-title":"Am J Rhinol","first-page":"281","article-title":"Endoscopic transnasal pituitary surgery: report on 180 cases","volume":"15","author":"Nasseri","year":"2001"},{"key":"b10-focus14694","series-title":"N Engl J Med","first-page":"243","article-title":"Results of treatment in 108 patients with Cushing's syndrome","volume":"285","author":"Orth","year":"1971"},{"issue":"3","key":"b11-focus14694","series-title":"Neurosurg Focus","first-page":"E7","article-title":"National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002","volume":"23","author":"Patil","year":"2007"},{"key":"b12-focus14694","series-title":"J Clin Endocrinol Metab","first-page":"1122","article-title":"Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease","volume":"69","author":"Pieters","year":"1989"},{"key":"b13-focus14694","series-title":"Clin Endocrinol (Oxf)","first-page":"621","article-title":"Transsphenoidal microsurgery for Cushing's disease","volume":"21","author":"Semple","year":"1984"},{"key":"b14-focus14694","series-title":"Endocrinol Metab Clin North Am","first-page":"459","article-title":"Pituitary surgery and postoperative management in Cushing's disease","volume":"34","author":"Utz","year":"2005"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/38\/2\/article-pE2.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/38\/2\/article-pE2.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/38\/2\/article-pE2.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:48:19Z","timestamp":1779526099000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/38\/2\/article-pE2.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2014.11.focus14694","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}